Germany· DE-A57-d3a548049e0302d3
Clindamycin Noridem
A medicinal product containing clindamycin, registered in Germany by Noridem Enterprises Ltd.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Clindamycin
- Manufacturer
- Noridem Enterprises Ltd
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clindamycin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCleocinPharmacia & Upjohn Company LLC
- United KingdomClindamycin 1% aqueous lotionPfizer Ltd
- FinlandAntirobe vet.Zoetis Animal Health ApS
- PolandClindacneBausch Health Ireland Ltd.
- CzechiaCLINDAMYCIN HAMELNhameln pharma gmbh, Hameln
- CanadaANTIROBEZOETIS CANADA INC
- SwedenClindamycin Abcur 150 mg/ml Injektions-/infusionsvätska, lösningAbcur AB
- SwitzerlandClindamycin [phosphat] Sandoz i.v./i.m. 600 mg/4ml, Konzentrat zur Herstellung einer Infusionslösung i.v. / Injektionslösung i.mSandoz Pharmaceuticals AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Clindac, Clindamycin 1a Pharma
- Belgium · Clindamycin Noridem, Clindamycin Sandoz
- Bulgaria · Clindamycin Kabi, Далацин C
- Cyprus · Arfarel, Clindamycin Abr
- Czechia · Clindamycin Hameln, Clindamycin Kabi
- Denmark · Clindamycin Abcur, Clindamycin Alternova
- Estonia · Clindamycin Mip, Dalacin
- Spain · Clindamicina Aristo, Clindamicina Kalceks
- Finland · Clindamycin Abcur, Clindamycin Fresenius Kabi
- France · Clindamycine Kabi, Clindamycine Kalceks
- United Kingdom (Northern Ireland) · Clindamycin, Clindamycin As Kalceks
- Greece · Cleo-Fort, Clidacin 1% Διάλυμα Εξωτερικήσ Χρήσησ
- Croatia · Aknet, Dalacin
- Hungary · Clindamycin Anfarm, Clindamycin Hameln
- Ireland · Clindamycin, Clindamycin Kalceks
- Iceland · Clindamycin Abcur, Clindamycin Eql Pharma
- Italy · Cleocin, Clindamicina Fosfato Bioindustria L.I.M.
- Lithuania · Clindamycin Mip, Dalacin C
- Luxembourg · Clindamycine Eg, Clindamycine Fresenius Kabi
- Latvia · Clindamycin Kalceks, Clindamycin Mip
- Malta · Clidacin Ba Free Amp, Clindamicina Accord
- Netherlands · Clindamycin Teva, Clindamycine Added Pharma
- Norway · Clindamycin Abcur, Clindamycin Kalceks
- Poland · Clindacne, Clindalin
- Portugal · Clincina, Clindamicina Generis
- Romania · Clindamicină Hameln, Clindamycin Mip
- Sweden · Clindamycin Abcur, Clindamycin Actavis
- Slovenia · Dalacin, Klimicin
- Slovakia · Clindamycin Hameln, Clindamycin Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ef0f32b5-0417-422c-a7f1-dbdfc005a6e4 GET /v1/drugs/ef0f32b5-0417-422c-a7f1-dbdfc005a6e4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use ,Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Clindamycin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about clindamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.